2026 Daniel D. Von Hoff: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	102	7509	7056	3920	3626	773	58011

Research.com Recognitions

1992 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Daniel D. Von Hoff is affiliated with the Translational Genomics Research Institute in the United States. Their research primarily spans the fields of medicine and biochemistry, genetics, and molecular biology, with a strong focus on oncology and molecular biology as notable subfields.

Their work covers a range of topics, including:

Pancreatic and Hepatic Oncology Research
Cancer Genomics and Diagnostics
Histone Deacetylase Inhibitors Research
Extracellular vesicles in disease
Cancer, Hypoxia, and Metabolism
MRI in cancer diagnosis
Radiomics and Machine Learning in Medical Imaging

Daniel D. Von Hoff has contributed to numerous scientific publications. Selected recent papers include:

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial, 2020, Nature Medicine
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions, 2020, Genome Medicine
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial, 2023, Journal of Clinical Oncology
An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study, 2022, Gastroenterology
Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth, 2022, Med

Their frequent publication venues include:

Cancer Research
Journal of Clinical Oncology
The Oncologist
Frontiers in Oncology
Gastroenterology

Frequent co-authors of Daniel D. Von Hoff are:

Haiyong Han
Erkut Borazanci
Derek Cridebring
Gayle Jameson
Ajay Goel

Daniel D. Von Hoff was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 1992.

Best Publications

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff;Thomas Ervin;Francis P. Arena;E. Gabriela Chiorean

6535
Citations
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Paolo P. Provenzano;Carlos Cuevas;Amy E. Chang;Vikas K. Goel

2056
Citations
Hypersensitivity reactions from taxol.

R B Weiss;R C Donehower;P H Wiernik;T Ohnuma

1533
Citations
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

Daniel D. Von Hoff;Patricia M. LoRusso;Charles M. Rudin;Josina C. Reddy

1331
Citations
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

Manuel Hidalgo;Lillian L. Siu;John Nemunaitis;Jinee Rizzo

1266
Citations
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey Hrkach;Daniel Von Hoff;Mir Mukkaram Ali;Elizaveta Andrianova

1257
Citations
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang-Gillam;Chung-Pin Li;György Bodoky;Andrew Dean

1245
Citations
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449

Charles M. Rudin;Christine L. Hann;John Laterra;Robert L. Yauch

1198
Citations
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Daniel D. Von Hoff;Ramesh K. Ramanathan;Mitesh J. Borad;Daniel A. Laheru

1194
Citations
Tumor-stroma interactions in pancreatic ductal adenocarcinoma

Daruka Mahadevan;Daniel D. Von Hoff

729
Citations
Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff;Joseph J. Stephenson;Peter Rosen;David M. Loesch

675
Citations
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

David Goldstein;Robert Hassan El-Maraghi;Pascal Hammel;Volker Heinemann

673
Citations
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development

Eric K. Rowinsky;Jolene J. Windle;Daniel D. Von Hoff

670
Citations
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

Martee L. Hensley;Karen L. Hagerty;Tarun Kewalramani;Daniel M. Green

664
Citations
Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis

Denis Drygin;Adam Siddiqui-Jain;Sean O'Brien;Michael Schwaebe

639
Citations
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

Patricia M. LoRusso;Charles M. Rudin;Josina C. Reddy;Raoul Tibes

620
Citations
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Clifford J. Whatcott;Caroline H. Diep;Ping Jiang;Aprill Watanabe

603
Citations
A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer

Ian Ganly;Ian Ganly;David Kirn;Susan G. Eckhardt;Gail I. Rodriguez

571
Citations
Daunomycin-induced cardiotoxicity in children and adults: A review of 110 cases

Daniel D. Von Hoff;Marcel Rozencweig;Maxwell Layard;Milan Slavik

568
Citations
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

William D Tap;Zev A Wainberg;Stephen P Anthony;Prabha N Ibrahim

559
Citations

Frequent Co-Authors

Ramesh K. Ramanathan Mayo Clinic

Gary M. Clark The University of Texas Health Science Center at San Antonio

John D. Carpten University of Southern California

Manuel Hidalgo Cornell University

David Goldstein University of New South Wales

David Craig University of Southern California

Josep Tabernero Vall d´Hebron Institute of Oncology

Patricia LoRusso Yale University

Jeffrey R. Infante Janssen (Belgium)

Jeffrey M. Trent Translational Genomics Research Institute

External Links

Wikipedia of Daniel D. Von Hoff Personal website of Daniel D. Von Hoff

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re interested in healthcare but looking for flexible or alternative pathways, there are a range of online degrees related to medicine in the USA. For aspiring nurses who want to take on advanced leadership or clinical roles, exploring the cheapest DNP programs online can be a smart way to earn a Doctor of Nursing Practice without high tuition costs.

Pharmacists are also in demand, and you can now pursue the cheapest online pharmacy school options to earn a pharmacy degree remotely, opening up new opportunities while managing expenses.

Beyond patient care, the field of health informatics is rapidly expanding. Professionals in this area bridge healthcare and technology, using data to improve patient outcomes and streamline medical services.

Many students begin their healthcare career by earning a credential in billing and coding. The average cost of medical billing and coding program is comparatively affordable, making this a good entry point for those seeking quick access to the workforce.